A 42-year-old schoolteacher began GLP-1 therapy for obesity and Type 2 diabetes. Within months, her appetite dropped sharply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results